Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06679621 · ClinicalTrials.gov registry record · NA
A Telehealth Intervention to Increase Patient Preparedness for Surgery in Latinas
A NA study of Incontinence and Prolapse, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 357
- Enrollment target
- 1
- Study location
NCT06679621: Recruiting NA study of Incontinence and Prolapse, sponsored by University of Alabama at Birmingham.
NCT06679621 is a NA study of Incontinence and Prolapse that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 357 participants, below the 510-participant average among 7 other Incontinence trials with a reported enrollment target (30% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06679621, a NA study of Incontinence and Prolapse, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 357 participants
- Enrollment target
- 1
- Study location
Study Summary
There are 3 aims of this study. In Aim 1 community patient partners will be enrolled to help guide the research being performed in all of the aims. Investigators will also administer a survey that will help determine factors associated with surgical preparedness. In Aim 2 investigators will develop an intervention to increase surgical preparedness using Human Centered Design Methods. Aim 3 will pilot test the intervention using mixed methods to determine feasibility and implementation outcomes.
Primary Outcome
A feasible study will be defined a 1) \>4 on 1-5 Likert-type scales of acceptability, appropriateness, and feasibility; 2) \>70% for adherence; and 3)\> 90% for dose delivery, and percent completed intervention. Acceptability will be measured by the Acceptability of the Intervention Measure Appropriateness will be measured by the Intervention Appropriateness Measure Feasibility will be measured by the Feasibility of Intervention Measure
Conditions Studied
Interventions
- BEHAVIORAL Telehealth intervention
Study Locations (1)
Alabama
- University of Alabama Birmginham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 357 participants |
| Start Date | 2024-11-11 |
| Est. Completion | 2027-06-01 |
| Phase | NA |
What NCT06679621 shows while recruiting
NCT06679621 is an interventional study that assigns participants to a tested intervention. The registered 357 participants enrollment target is mid-sized for trials with a published cap, below the 510-participant average among 7 other Incontinence trials with a reported enrollment target (30% lower).
The record links to 2 conditions, with Incontinence appearing as the primary indexed condition, and to 1 intervention - of which Telehealth intervention is the first listed.
NCT06679621 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT06679621 about?
NCT06679621 is a clinical study titled "A Telehealth Intervention to Increase Patient Preparedness for Surgery in Latinas". There are 3 aims of this study. In Aim 1 community patient partners will be enrolled to help guide the research being performed in all of the aims. Investigators will also administer a survey that will help determine factors associated with surgical preparedness. In Aim 2 investigators will develop ...
What is the current status of trial NCT06679621?
This trial is currently recruiting. It is a NA study. The enrollment target is 357 participants. The study started on 2024-11-11. Estimated completion is 2027-06-01.
What conditions does trial NCT06679621 study?
This clinical trial studies the following conditions: Incontinence, Prolapse.
What interventions are being tested in trial NCT06679621?
The interventions under investigation include: Telehealth intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06679621?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06679621 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Electrical Stimulation for Continence After Spinal Cord Injury
ACTIVE NOT RECRUITING · NA
-
UTI Prophylaxis With Cranberry Extract After Female Incontinence Surgery
COMPLETED · NA
-
Toilet Training Toddlers and Preschoolers
COMPLETED · NA
-
Interventions to Decrease Anxiety in Patients Undergoing Urodynamic Testing
COMPLETED · NA
-
TReating Incontinence for Underlying Mental and Physical Health
RECRUITING · Phase 4
-
The Women's Urology Center/WISH Database Project
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06062888 · 357 participants · Phase 2
FFP In Traumatic BRAin INjury (FIT-BRAIN) Trial
- NCT06109766 · 357 participants · NA
Delivering Evidence-Based Parenting Services to Families in Child Welfare Using Telehealth
- NCT06231342 · 357 participants · NA
Endotracheal Tube (ETT) 180: Stylet-loaded Endotracheal Tube Rotation Before Insertion
- NCT06533826 · 357 participants · Phase 2
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI